News Interim report for the first nine months of 2022 Please read the full announcement in PDF Attachment 2022_27_Q32022_CompanyAnnouncement Read moreUltimate Guide: Everything You Need to Know About Industry 4.0 Continue Reading Previous Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022Next APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 Related Stories News Intellias strengthens cloud transformation capabilities as one of only 19 Google Cloud DevOps specialists worldwide News Brizy Launches Brizy Shops: Design Your Dream Online Store, Code-Free News Eagle Football Holdings supports Leadership Changes at Olympique Lyonnais News Ten innovative youth-led housing solutions win a total of US$40,000 in grants from Habitat for Humanity News Chagee’s Global Potential Far Outpaces Its 15x PE Valuation News Transnusa Strengthens Network Connectivity in 2025
